Cargando…

The European Vasculitis Society 2016 Meeting Report

The 2016 European Vasculitis Society (EUVAS) meeting, held in Leiden, the Netherlands, was centered around phenotypic subtyping in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV). There were parallel meetings of the EUVAS petals, which here report on disease assessment; databa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bajema, Ingeborg M., Bruijn, Jan A., Casian, Alina, Cid, Maria C., Csernok, Elena, van Daalen, Emma, Harper, Lorraine, Hauser, Thomas, Little, Mark A., Luqmani, Raashid A., Mahr, Alfred, Ponte, Cristina, Salama, Alan, Segelmark, Mårten, Suzuki, Kazuo, Sznajd, Jan, Teng, Y.K. Onno, Vaglio, Augusto, Westman, Kerstin, Jayne, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Meeting Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733672/ https://www.ncbi.nlm.nih.gov/pubmed/29634043 http://dx.doi.org/10.1016/j.ekir.2017.09.008

Ejemplares similares

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts
por: Yates, Max, et al.
Publicado: (2017)

The Sound of Interconnectivity; The European Vasculitis Society 2022 Report
por: Egan, Allyson C., et al.
Publicado: (2022)

Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis
por: Monti, Sara, et al.
Publicado: (2019)

Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis
por: Águeda, Ana F, et al.
Publicado: (2019)

Podocytes and Proteinuria in ANCA-Associated Glomerulonephritis: A Case-Control Study
por: van Daalen, Emma E., et al.
Publicado: (2019)

The COVID-19 pandemic and ANCA-associated vasculitis – reports from the EUVAS meeting and EUVAS education forum
por: Kronbichler, Andreas, et al.
Publicado: (2021)

Neutrophil Extracellular Traps in ANCA-Associated Vasculitis
por: Söderberg, Daniel, et al.
Publicado: (2016)

Anti-plasminogen antibodies in ANCA-associated vasculitis: An optimized anti-plasminogen assay
por: Göçeroğlu, Arda, et al.
Publicado: (2018)

Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1—treatment of granulomatosis with polyangiitis and microscopic polyangiitis
por: Schirmer, Jan Henrik, et al.
Publicado: (2023)

Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): Part 2 - Treatment of eosinophilic granulomatosis with polyangiitis and diagnosis and general management of AAV
por: Sanchez-Alamo, Beatriz, et al.
Publicado: (2023)

Time to focus on outcome assessment tools for childhood vasculitis
por: Demirkaya, Erkan, et al.
Publicado: (2011)

Marginal-Zone B-Cells Are Main Producers of IgM in Humans, and Are Reduced in Patients With Autoimmune Vasculitis
por: Appelgren, Daniel, et al.
Publicado: (2018)

Monocyte Chemoattractant Protein 1 is a Prognostic Marker in ANCA-Associated Small Vessel Vasculitis
por: Ohlsson, Sophie, et al.
Publicado: (2009)

Streptococcal Enzymes as Precision Tools Against Pathogenic IgG Autoantibodies in Small Vessel Vasculitis
por: Segelmark, Mårten, et al.
Publicado: (2019)

Infection is associated with increased risk of MPO- but not PR3-ANCA-associated vasculitis
por: Rathmann, Jens, et al.
Publicado: (2022)

The Diagnostic and Clinical Utility of Autoantibodies in Systemic Vasculitis
por: Csernok, Elena
Publicado: (2019)

Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome?
por: Ohlsson, Sophie, et al.
Publicado: (2004)

The HAVEN study—hydroxychloroquine in ANCA vasculitis evaluation—a multicentre, randomised, double-blind, placebo-controlled trial: study protocol and statistical analysis plan
por: Learoyd, Annastazia E., et al.
Publicado: (2023)

Risk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID‐19: A Binational, Registry‐Based Cohort Study
por: Rutherford, Matthew A., et al.
Publicado: (2021)

COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab
por: Bruchfeld, Annette, et al.
Publicado: (2021)

Autoantibodies Against Lysosome Associated Membrane Protein-2 (LAMP-2) in Pediatric Chronic Primary Systemic Vasculitis
por: Gibson, Kristen M., et al.
Publicado: (2021)

Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal
por: Latimer, Nicholas R., et al.
Publicado: (2014)

Stable incidence but increase in prevalence of ANCA-associated vasculitis in southern Sweden: a 23-year study
por: Rathmann, Jens, et al.
Publicado: (2023)

New concepts in ANCA detection and disease classification in small vessel vasculitis: the role of ANCA antigen specificity
por: Csernok, Elena
Publicado: (2018)

Decreased Neutrophil Apoptosis in Quiescent ANCA-Associated Systemic Vasculitis
por: Abdgawad, Mohamed, et al.
Publicado: (2012)

Reuma.pt/vasculitis – the Portuguese vasculitis registry
por: Ponte, Cristina, et al.
Publicado: (2020)

State of the Art in the Treatment of Systemic Vasculitides
por: Luqmani, Raashid Ahmed
Publicado: (2014)

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Robson, Joanna C., et al.
Publicado: (2017)

Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient Preferences
por: Collister, David, et al.
Publicado: (2022)

Nephrin Loss Can Be Used to Predict Remission and Long-term Renal Outcome in Patients With Minimal Change Disease
por: van de Lest, Nina A., et al.
Publicado: (2017)

ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse
por: Göçeroğlu, Arda, et al.
Publicado: (2016)

Response to “Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation”
por: van Leeuwen, Jolijn R., et al.
Publicado: (2022)

Diagnostic Value of Procalcitonin in ANCA-Associated Vasculitis (AAV) to Differentiate Between Disease Activity, Infection and Drug Hypersensitivity
por: Herrmann, K, et al.
Publicado: (2015)

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
por: Robson, Joanna C, et al.
Publicado: (2018)

Localized Forms of Vasculitis
por: Martins-Martinho, Joana, et al.
Publicado: (2021)

Clinical Trials in Vasculitis
por: Gopaluni, Seerapani, et al.
Publicado: (2016)

Clinical Practice Audit on the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Netherlands
por: Dirikgil, Ebru, et al.
Publicado: (2021)

Challenges of defining renal response in ANCA-associated vasculitis: call to action?
por: Odler, Balazs, et al.
Publicado: (2023)

Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Randomized Controlled Study
por: Jayne, David, et al.
Publicado: (2019)

Telomere dysfunction promotes small vessel vasculitis via the LL37-NETs-dependent mechanism
por: Lu, Yingying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7oi06q1d00n09nthg2geguug26